Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

Glenwood D. Goss, Chun‐Ming Tsai, Frances A. Shepherd et al. · The Lancet Oncology · 2016

Cited by 645 works. doi:10.1016/s1470-2045(16)30508-3

Authors

References